Covid-19 Response Covid-19 Response Covid-19 Response
  • COVID-19 HOME
  • TOPIC AREAS
    • Discharge Criteria
      • Overview
      • Key Questions We Studied
      • Reference Materials from Collaborators
      • Links to Resources from Collaborators
    • Workforce Planning
      • Overview
      • Key Questions We Studied
      • Tables & Endnotes
    • Provider Wellness
                and Support
      • Overview
      • Key Clinical Questions
      • Useful Resources
      • References
    • Patient Experience
      • Overview
      • Key Clinical Questions
      • Recommended “Better” Practices
      • Inpatient Visitor Restriction Policies: A Quick Toolkit
    • Medical Education
      • Overview
      • Key Clinical Questions
    • Clinical Pathways
                and Documentation
      • Clinical Pathways Overview
        • Key Questions We Studied
        • Endnotes
      • Thromboembolism and Anticoagulation Overview
        • Key Questions We Studied
        • Endnotes
  • CONTACT
  • COVID-19 HOME
  • TOPIC AREAS
    • Discharge Criteria
      • Overview
      • Key Questions We Studied
      • Reference Materials from Collaborators
      • Links to Resources from Collaborators
    • Workforce Planning
      • Overview
      • Key Questions We Studied
      • Tables & Endnotes
    • Provider Wellness
                and Support
      • Overview
      • Key Clinical Questions
      • Useful Resources
      • References
    • Patient Experience
      • Overview
      • Key Clinical Questions
      • Recommended “Better” Practices
      • Inpatient Visitor Restriction Policies: A Quick Toolkit
    • Medical Education
      • Overview
      • Key Clinical Questions
    • Clinical Pathways
                and Documentation
      • Clinical Pathways Overview
        • Key Questions We Studied
        • Endnotes
      • Thromboembolism and Anticoagulation Overview
        • Key Questions We Studied
        • Endnotes
  • CONTACT
01. What is COVID-19–associated coagulopathy (CAC), and how does it compare to DIC?20200822195848

01. What is COVID-19–associated coagulopathy (CAC), and how does it compare to DIC?

AdminAugust 22, 20200 comments
71% of institutions referred to COVID-19–associated coagulopathy based on specific laboratory parameters and an increased risk for thrombosis. ...
Read more
Previous
12
Next

Recent Posts

  • 3. What key advice did hospital medicine leaders want to share related to clinical practice standardization during the COVID-19 pandemic?
  • 2. How do practices in key clinical domains vary across institutions? (12 Key Items Addressed)
  • 1. Are hospitals providing clinical guidance on COVID-19 to their frontline workers? And if so, how is this guidance developed and disseminated?
  • 06. Conceptual/Philosophical/Value Statements by Leadership
  • 05. Changes in Daily Routines

Recent Comments

    Archives

    • June 2021
    • March 2021
    • January 2021
    • December 2020
    • September 2020
    • August 2020

    Categories

    • Clinical Pathways
    • Discharge Criteria
    • Medical Education
    • Patient Experience
    • Provider Wellness
    • VTE Clinical Questions
    • Workforce

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    • RETURN TO HOMERuN
       
    • COVID-19 HOME
       
    • TOPIC AREAS
      • + Discharge Criteria
      • + Workforce Planning
      • + Provider Wellness and Support
      • + Patient Experience
      • + Medical Education
      • + Clinical Pathways and Documentation
         
    • CONTACT ADMINISTRATOR




    ©2020 HOMERuN Hospital Medicine ReEngineering Network COVID 19 Collaboration